Q3 2019 Holdings
Filed 2019-11-14 | 49 holdings | $29.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $18.5M | 1,350,000 | 63.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.2M | 200,000 | 24.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $3.1M | 207,000 | 10.7% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $14.3K | 4,070,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $14.1K | 1,365,000 | 0.0% |
| Harrow Health | COM | 45323A201 | $13.3K | 2,370,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $11.0K | 305,550 | 0.0% |
| Turning Point Therapeutics Inc | COM | 90041T108 | $10.8K | 287,500 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $9.8K | 645,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $9.1K | 350,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.4K | 2,775,000 | 0.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $8.4K | 700,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $8.1K | 205,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $8.0K | 440,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $8.0K | 285,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $7.8K | 230,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.7K | 105,000 | 0.0% |
| Cytokinetics | COM NEW | 23282W905 | $7.4K | 650,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $7.4K | 375,000 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $7.4K | 1,165,000 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $7.2K | 2,185,536 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $6.7K | 160,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $6.4K | 190,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $6.0K | 195,000 | 0.0% |
| Avenue Therapeutics Inc | COM NEW | 05360L205 | $5.7K | 952,600 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.5K | 150,000 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $4.8K | 160,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $4.2K | 170,000 | 0.0% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $4.1K | 185,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $4.0K | 385,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.4K | 612,500 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $3.4K | 141,800 | 0.0% |
| Synthorx Inc | COM | 87167A103 | $2.9K | 180,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $2.8K | 995,000 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COM | 34983P104 | $2.7K | 425,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $2.6K | 85,000 | 0.0% |
| Fortress Biotech Inc | COM | 034960Q19 | $2.3K | 1,655,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $1.9K | 75,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $1.5K | 720,000 | 0.0% |
| Flexion Therapeutics Inc | COM | 33938J106 | $1.4K | 105,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $1.4K | 200,000 | 0.0% |
| Edap TMS SA(EDA) | SPONSORED ADR | 268311107 | $1.3K | 300,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.3K | 170,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $1.2K | 490,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $717 | 140,000 | 0.0% |
| Vermillion Inc | COM NEW | 92407M206 | $661 | 1,265,000 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $492 | 50,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $44 | 16,667 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $14 | 54,000 | 0.0% |